Early coronavirus vaccine results show no major safety issue

By: |
September 3, 2020 2:13 PM

The work was sponsored by the Coalition for Epidemic Preparedness Innovations, a nonprofit focused on increasing vaccine availability worldwide.

Three other experimental vaccines are in late-stage testing in the United States.Three other experimental vaccines are in late-stage testing in the United States.

Early results from an experimental coronavirus vaccine show no major safety problems and suggest that it spurs the desired immune system responses, researchers reported on Wednesday in the New England Journal of Medicine.

The US government has awarded Novavax, a company based in Gaithersburg, Maryland, USD 1.6 billion to help develop and make the vaccine, which is given as two shots, three weeks apart. It includes a protein from the coronavirus to prompt the immune system to make antibodies to fight infection.

The study tested two dose levels in 108 healthy people and compared responses to 23 others who got placebo shots. Most of those given vaccine also received an adjuvant — a substance often included in vaccines to boost the immune system’s response and stretch a limited supply.

The adjuvant seemed safe; those who got it with the lower dose made antibodies in far greater numbers than what’s typically seen in people recovering from natural infection with COVID-19, researchers reported.

The work was sponsored by the Coalition for Epidemic Preparedness Innovations, a nonprofit focused on increasing vaccine availability worldwide.

Three other experimental vaccines are in late-stage testing in the United States.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Covid-19 cases surge in Delhi again, number of containment zones tops 2,000
2Coronavirus spreading through air? CSIR begins study to find out possibility of airborne transmission of COVID-19
3COVID-19, dengue double attack in Delhi NCR! Double infection’s treatment tricky, needs balanced approach, say Doctors